文献速递瓣膜病与结构性心脏病

多巴酚丁胺负荷超声心动图评估低流速低跨瓣压差主动脉瓣狭窄:指南标准验证与AVAProj的价值

Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

结果显示这些标准分类准确性有限,而标准化流量下投影AVA(AVAProj ≤1 cm2)分类更准确且与保守治疗患者死亡率强相关。

要点

  • 指南DSE标准(MG≥40 mm Hg或MG≥40+AVA≤1 cm2)对真实重度AS分类准确性仅47-60%。
  • AVAProj ≤1 cm2分类准确性达70%,优于所有指南标准。
  • AVAProj ≤1 cm2是保守治疗患者死亡的强预测因子(HR 3.65)。

核心结论

  • 在低LVEF的LF-LG AS患者中,指南推荐的DSE标准(峰值负荷MG ≥40 mm Hg或MG ≥40 mm Hg复合AVA ≤1 cm2)对预测真实狭窄严重程度和结局价值有限。
  • AVAProj能更好区分真性与假性重度AS,并与保守治疗患者的死亡率强相关。

研究设计与样本

  • 通过瓣膜置换时宏观评估(54例)、CT测主动脉瓣钙化(25例)或两者(8例)独立验证AS严重程度。

主要发现

  • 峰值负荷MG ≥40 mm Hg、峰值负荷AVA ≤1 cm2、两者组合分别正确分类48%、60%、47%的患者。
  • AVAProj ≤1 cm2正确分类70%,优于上述所有指标(p < 0.007)。
  • 保守治疗亚组88例中52例死亡,随访2.8 ± 2.5年。
  • 调整年龄、性别、功能状态、慢性肾衰竭和峰值负荷LVEF后,峰值负荷MG和AVA不是死亡预测因子。
  • AVAProj ≤1 cm2是保守治疗患者死亡的强预测因子(HR 3.65;p = 0.0003)。

关键数值与推荐

  • 峰值负荷MG ≥40 mm Hg且峰值负荷AVA ≤1 cm2为指南定义的真性重度AS标准,但正确分类仅47%。
  • AVAProj ≤1 cm2分类准确性70%,优于指南标准(p < 0.007)。
  • AVAProj ≤1 cm2预测保守治疗死亡HR 3.65(p = 0.0003)。

临床怎么用

  • 对于低LVEF的LF-LG AS患者,不应仅依赖指南DSE标准(MG ≥40 mm Hg和/或AVA ≤1 cm2)判断真实重度狭窄。
  • 计算AVAProj(标准化正常流量下投影AVA)可提高鉴别真性与假性重度AS的准确性,并有助于风险分层。
  • AVAProj ≤1 cm2提示保守治疗死亡风险高,可能有助于支持瓣膜置换决策。

局限性

  • 仅部分患者(87例)有独立验证AS严重程度(宏观评估和/或CT钙化),样本量有限。
  • 保守治疗亚组样本量较小(88例),事件数有限。
  • 研究为前瞻性队列,但需外部验证确认AVAProj的普适性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the American College of Cardiology/American Heart Association guidelines, patients are considered to have true-severe stenosis when the mean gradient (MG) is ≥40 mm Hg with an aortic valve area (AVA) ≤1 cm2 during dobutamine stress echocardiography (DSE). However, these criteria have not been previously validated. OBJECTIVES: The aim of this study was to assess the value of these criteria to predict the presence of true-severe AS and the occurrence of death in patients with low-flow, low-gradient aortic stenosis (LF-LG AS). METHODS: One hundred eighty-six patients with low left ventricular ejection fraction (LVEF) LF-LG AS were prospectively recruited and underwent DSE, with measurement of the MG, AVA, and the projected AVA (AVAProj), which is an estimate of the AVA at a standardized normal flow rate. Severity of AS was independently corroborated by macroscopic evaluation of the valve at the time of valve replacement in 54 patients, by measurement of the aortic valve calcium by computed tomography in 25 patients, and by both methods in 8 patients. According to these assessments, 50 of 87 (57%) patients in the study cohort had true-severe stenosis. RESULTS: Peak stress MG ≥40 mm Hg, peak stress AVA ≤1 cm2, and the combination of peak stress MG ≥40 mm Hg and peak stress AVA ≤1 cm2 correctly classified AS severity in 48%, 60%, and 47% of patients, respectively, whereas AVAProj ≤1 cm2 was better than all the previous markers (p < 0.007), with 70% correct classification. Among the subset of 88 patients managed conservatively (47% of the cohort), 52 died during a follow-up of 2.8 ± 2.5 years. After adjustment for age, sex, functional capacity, chronic kidney failure, and peak stress LVEF, peak stress MG and AVA were not predictors of mortality in this subset. In contrast, AVAProj ≤1 cm2 was a strong predictor of mortality under medical management (hazard ratio: 3.65; p = 0.0003). CONCLUSIONS: In patients with low LVEF LF-LG AS, the DSE criteria of a peak stress MG ≥40 mm Hg, or the composite of a peak stress MG ≥40 mm Hg and a peak stress AVA ≤1 cm2 proposed in the guidelines to identify true-severe AS and recommend valve replacement, have limited value to predict actual stenosis severity and outcomes. In contrast, AVAProj better distinguishes true-severe AS from pseudo-severe AS and is strongly associated with mortality in patients under conservative management. (Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis [TOPAS]; NCT01835028).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Annabi MS, Touboul E, Dahou A, et al. Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis. J Am Coll Cardiol. 2018. PMID: 29406851. doi:10.1016/j.jacc.2017.11.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。